MedPath
FDA Approval

PROMETHAZINE HYDROCHLORIDE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 9, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Promethazine(50 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PROMETHAZINE HYDROCHLORIDE

Product Details

NDC Product Code
39822-5550
Application Number
ANDA040737
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR, INTRAVENOUS
Effective Date
January 9, 2024
CALCIUM CHLORIDEInactive
Code: M4I0D6VV5MClass: IACTQuantity: 0.01 mg in 1 mL
SODIUM METABISULFITEInactive
Code: 4VON5FNS3CClass: IACTQuantity: 0.25 mg in 1 mL
EDETATE SODIUMInactive
Code: MP1J8420LUClass: IACTQuantity: 0.1 mg in 1 mL
PHENOLInactive
Code: 339NCG44TVClass: IACTQuantity: 5 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM ACETATEInactive
Code: 4550K0SC9BClass: IACT
ACETIC ACIDInactive
Code: Q40Q9N063PClass: IACT
Code: R61ZEH7I1IClass: ACTIBQuantity: 50 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath